Results 171 to 180 of about 305,145 (241)

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma. [PDF]

Nat Commun
Mao L, Lai Y, Zheng H, Cui M, Li L, Liu Z, Zhou H, Sun L, Li C, Wei X, Gu J, Bai X, Kong Y, Cui C, Chi Z, Sheng X, Lian B, Li S, Yan X, Tang B, Li J, Zhou L, Wang X, Guo J, Dai J, Si L.   +25 more
europepmc   +1 more source

Lachnospiraceae in the Food–Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 6, November 2026.
ABSTRACT The interplay between diet, gut microbiota, and host immunity is central to food science. The Lachnospiraceae family ferments dietary fibers to produce short‐chain fatty acids (SCFAs), notably butyrate and propionate, with immunomodulatory potential. This critical review distinguishes established findings from hypotheses.
Ruijun Wang, Zhiqi Li, Lina Zhang, Yuanming Pan, Zhanbiao He   +4 more
wiley   +1 more source

Analysis of Treatment Patterns for Mucosal Melanoma Using Real-World Data in the SEER-Medicare-Linked Database. [PDF]

Cancer Med
Zakeri M, Wagner S, Zhu X, Baser O.
europepmc   +1 more source

Pan‐Cancer Analysis of the Immunomodulatory Roles and Prognostic Value of PDXP and Experimental Verification in SKCM

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Multiple public databases, including TCGA, GEO, and TARGET, were utilized to comprehensively analyze pyridoxal phosphatase (PDXP) expression profiles across 34 cancer types. We further explored the associations of PDXP expression with clinicopathological features, tumor immune microenvironment, genomic heterogeneity, functional signaling ...
Yingjian Hu, Xinzhu Zeng, Wei Cao, Jianhao Jiao, Yuan Zhao, Jun Wang   +5 more
wiley   +1 more source

Effectiveness and Mechanism of Cryoablation in the Treatment of Oral Mucosal Melanoma. [PDF]

Cancer Med
You Z, Zhang T, Dai L, Wen J, Liu M, Zhao T, Yin G, Wu Y, Zhang S.   +8 more
europepmc   +1 more source

The Impact of SF3B1 Mutations on the Tumor Microenvironment and Response to Immunotherapy

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Cancer genomes shape the immune landscape within the tumor microenvironment (TME), thereby influencing host antitumor immunity. Identifying somatic mutations that modulate the TME is critical for selecting patients most likely to benefit from immunotherapy.
Kyung‐Jin Cho, Byungho Lim
wiley   +1 more source

Severe Cryptosporidiosis Following Tumor-Infiltrating Lymphocyte Therapy in a Patient With Metastatic Mucosal Melanoma. [PDF]

ACG Case Rep J
Gill G, Saab O, Patel K, Bhattacharyya AK, Roden D, Aggarwal A.   +5 more
europepmc   +1 more source

Multiple Primary Malignancies Involving Papillary Thyroid Carcinoma: A Three‐Case Series

Clinical Case Reports, Volume 14, Issue 10, October 2026.
Patients with papillary thyroid carcinoma may develop distinct additional primary malignancies. New lesions or lymphadenopathy should not be presumed to represent metastatic PTC without tissue confirmation, emphasizing accurate diagnosis, multidisciplinary evaluation, and individualized treatment.
Katayoon Ghasemi, Amirhossein Rezaei Latifi, Mohammad Salari   +2 more
wiley   +1 more source

Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review. [PDF]

Head Neck
Kahloon L, Ishteiwy R, Gupta T, Albert C, Crawford D, Liu Z, Kong M, Dunlap N, Cash E, Townsend M.   +9 more
europepmc   +1 more source

Fecal Microbiota Transplantation and Microbiota‐Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 871-889, October 2026.
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó, Dorina Korózs, Michal Bator, Krisztina Jeszenszky, Viktor Lakatos, László Gopcsa, Péter Reményi, János Sinkó   +7 more
wiley   +1 more source